Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Stock
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.8 TRY | -1.50% | -2.41% | -5.54% |
Sales 2022 | 269M 8.31M | Sales 2023 | 238M 7.36M | Capitalization | 2.74B 84.66M |
---|---|---|---|---|---|
Net income 2022 | 330M 10.2M | Net income 2023 | -137M -4.23M | EV / Sales 2022 | 16.1 x |
Net cash position 2022 | 411M 12.71M | Net cash position 2023 | 336M 10.38M | EV / Sales 2023 | 10.1 x |
P/E ratio 2022 |
14.3
x | P/E ratio 2023 |
-20
x | Employees | 171 |
Yield 2022 |
2.76% | Yield 2023 |
-
| Free-Float | 25.33% |
1 day | -1.84% | ||
1 week | -2.41% | ||
Current month | -2.08% | ||
1 month | -14.10% | ||
3 months | -13.34% | ||
6 months | -12.17% | ||
Current year | -5.54% |
Managers | Title | Age | Since |
---|---|---|---|
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 11.8 | -1.50% | 361 521 |
24-06-07 | 11.98 | -2.04% | 1,822,204 |
24-06-06 | 12.23 | -0.24% | 3,877,914 |
24-06-05 | 12.26 | +0.49% | 3,564,620 |
24-06-04 | 12.2 | +1.24% | 1,353,066 |
Delayed Quote Borsa Istanbul, June 10, 2024 at 03:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.54% | 81.44M | |
+51.85% | 57.87B | |
+41.70% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ANGEN Stock